A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Against the backdrop of the 43rd Annual J.P. Morgan Healthcare Conference, Mayo Clinic announced the formation of Mayo Clinic Digital Pathology, designed on a platform architecture to boldly unlock ...

Continue to advance preclinical and research pipeline, including key programs selectively combined with Alector Brain Carrier, enhancing the ...

A recent study has linked thyroid and liver proteins, transthyretin (TTR) and apolipoprotein A-I (ApoA-I), to brain health, ...

Researchers at Nanyang Technological University in Singapore have identified a new “energy switch” in immune cells of the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

Company to Present Breakthrough Research Approach for a New Generation of Neurodegenerative Therapeutics GAINESVILLE, Fla., ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...